Stathmin1 regulates p27 expression, proliferation and drug resistance, resulting in poor clinical prognosis in cholangiocarcinoma

Patients with extrahepatic cholangiocarcinoma (EHCC) have a poor prognosis; postoperative survival depends on cancer progression and therapeutic resistance. The mechanism of EHCC progression needs to be clarified to identify ways to improve disease prognosis. Stathmin1 (STMN1) is a major cytosolic p...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Cancer Sci
Glavni autori: Watanabe, Akira, Suzuki, Hideki, Yokobori, Takehiko, Tsukagoshi, Mariko, Altan, Bolag, Kubo, Norio, Suzuki, Shigemasa, Araki, Kenichiro, Wada, Satoshi, Kashiwabara, Kenji, Hosouchi, Yasuo, Kuwano, Hiroyuki
Format: Artigo
Jezik:Inglês
Izdano: BlackWell Publishing Ltd 2014
Teme:
Original Articles
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4317896/
https://ncbi.nlm.nih.gov/pubmed/24708177
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.12417
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items